Global Cardiovascular Devices Market Expected to Reach USD 101.3 Billion by 2033 - IMARC Group

Global Cardiovascular Devices Market Statistics, Outlook and Regional Analysis 2025-2033

The global cardiovascular devices market size was valued at USD 62.3 Billion in 2024, and it is expected to reach USD 101.3 Billion by 2033, exhibiting a growth rate (CAGR) of 5.5% from 2025 to 2033.

This market is being primarily influenced by the increasing prevalence of cardiovascular diseases (CVDS) such as heart failure, coronary artery disease, and arrhythmias. It is stated that CVDs caused 17.9 million deaths over a period of time as short as one year. Heart diseases were estimated to have claimed 680,909 people in the US alone during 2023. Heart failure is further estimated to afflict 6.7 million Americans above the age of 20. This figure will grow to a staggering 11.4 million by the year 2050. The practitioners of modern lifestyle that is most often comprised of bad dietary practices, low-level physical activities, tobacco intake, and stress have largely contributed to the number of people experiencing heart problems. It has further caused an increase in the demand for devices such as pacemakers, stents, defibrillators, and heart monitors. The increasing burden within the healthcare systems has been addressed, and there have been investments by the government and the private sector in order to make early detection and cure possible. Today, with the advanced cardiovascular devices, patients are managed properly and thus life expectancy has marked an improvement. With the growing population turning health conscious, more and more people are using preventative and treatment technologies, and this is increasing the size of the market.

The growing geriatric population is one of the primary drivers of demand for cardiovascular equipment. As people age, their chance of developing heart disease increases dramatically. According to studies, by 2050, an incredible 20% of the world's population would be 65 or older, with cardiovascular diseases (CVD) accounting for 40% of all fatalities. Chronic conditions include hypertension, atherosclerosis, and arrhythmias, which commonly afflict elderly patients and thus lead to the use of specialized medical equipment for continued treatment. In response, healthcare providers are responding with targeted solutions appropriate for elderly patients, including smaller, more user-friendly devices with simpler interfaces. There is also an increasing focus on early detection and management of CVDs in order to reduce the effect of coronary deaths. Wearable health technologies are in this context important because through smartwatches and rings, people have become significant instruments in monitoring their health. Right now, about 44% of Americans own wearables. That comes with the determination seen in a 2024 survey in which 28% of users received health alerts via devices. Among those, 84% valued the data, and 76% successfully identified health issues after consulting a doctor. These trends highlight the increasing reliance on technology for preventive care and its potential in improving outcomes.

Global Cardiovascular Devices Market Statistics, By Region

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share on account of advanced healthcare infrastructure and high prevalence of CVDs.

North America Cardiovascular Devices Market Trends:

North America is the cardiovascular device market leader in the entire world because of its high incidences of heart disease, sophisticated medical system, and continued readiness for new technologies. Some estimates indicate that more than 18.2 million Americans suffered from coronary artery disease and more than 6 million had heart failure. It also has strong government payment and financing programs supportive of the industry's development. Apart from the above, other devices include smart watches and portable ECG monitors have become widely popular with the shift in attitudes towards the preventive health feature. Also, growing population of the elderly citizens of both Canada and the United States has expanded the devices market as well.

Asia-Pacific Cardiovascular Devices Market Trends:

Asia-Pacific's market for cardiovascular device is affected mainly due to high health care costs, population of the middle class, and high rate of urbanization. There is a growing number of lifestyle-related cardiovascular diseases across the population of China, India, and Japan due to unhealthy diet and sedentary lifestyle. The governments of these countries are investing in their healthcare infrastructure and expanding accessibility to modern medicine. This growth in the region is further promoted by the application of relatively inexpensive cardio equipment and growing medical tourism in a country like India.

Europe Cardiovascular Devices Market Trends:

Europe is a significant contributor to this industry due to its prevalence of cardiovascular diseases and interest in healthcare innovation. The countries that lead in this area are Germany, France, and the United Kingdom. The local administration is also initiating projects that help in early detection and treatment of cardiovascular diseases. The aging population in the region is also contributing to the increased demand for cardiac monitoring equipment, pacemakers, and stents.

Latin America Cardiovascular Devices Market Trends:

The market for cardiovascular devices in Latin America evolved is in sync with the improvement of the healthcare system in the region, as well as with increasing public awareness of heart healthcare. Countries such as Brazil, Mexico and Argentina are seen as the emerging markets within the area complimented by an older population coupled with a very high incidence of cardiovascular disease. Collaborative efforts are made by the government to expand health services and market early diagnosis of chronic diseases. Multinational agreements and investments also make modern devices of cardiovascular technology available to everyone, although the incorporation of new medical technologies remains still at infancy stages.

Middle East and Africa Cardiovascular Devices Market Trends:

Main drivers behind the growth of the Middle East and African cardiovascular devices market include rising health-care expenditures and heart disease that have become highly prevalent over time. As government policies of healthcare reforms begin, some of these nations' development, particularly South Africa, the United Arab Emirates, and Saudi Arabia are now in line with such innovations. Advanced cardiovascular devices are increasingly being used and preferred, especially in urban setups where access to proper expert treatment is easy. A good example of future prospects for the region is portrayed by the rising cases of various conditions such as hypertension and diabetes.

Top Companies Leading in the Cardiovascular Devices Industry

Some of the leading cardiovascular devices market companies include Abbott Laboratories, B. Braun Melsungen AG, Biotronik, Boston Scientific Corporation, Canon Medical Systems Corporation, Cardinal Health Inc., Edwards Lifesciences Corporation, General Electric Company, LivaNova PLC, Medtronic PLC, Siemens Healthineers GmbH (Siemens AG), Terumo Cardiovascular Systems Corporation (Terumo Corporation), among many others.

In April 2024, Abbott Laboratories announced that TriClip, a device for repairing heart valves, has received FDA approval for use in patients with potentially fatal cardiac conditions. The purpose of this device is to treat tricuspid regurgitation (TR), a condition in which blood flows backwards caused by improper closure of the valve that separates the right upper chamber of the heart from the right lower chamber.

Global Cardiovascular Devices Market Segmentation Coverage

• On the basis of the device type, the market has been classified into diagnostic and monitoring devices (electrocardiogram (ECG), remote cardiac monitoring, and others) and therapeutic and surgical devices (cardiac rhythm management (CRM) devices, catheter, stents, heart valves, and others). Therapeutic and surgical devices are the most dominant segment. Therapeutic and surgical devices, like the use of pacemakers and stents, manage the growing incidence of conditions that require intervention for heart diseases. These devices are basic to emergency procedures and long-term management, and hence their wide use globally.
• Based on the application, the market is segmented into coronary artery disease (CAD), cardiac arrhythmia, heart failure, and others, among which coronary artery disease (CAD) leads the market. Since coronary artery disease is the cause of death globally, there is a massive market for diagnostic and treatment options. They can further fortify their market domination by treating it with modern equipment like coronary angioplasty systems and drug-eluting stents.
• On the basis of the end user, the market has been divided into hospitals, specialty clinics, and others. Among these, hospitals account for the majority of the market share. Hospitals are the bases for cardiovascular procedures like surgeries and diagnostics because of the advanced facilities and qualified professionals. All these cutting-edge technologies and infrastructures make them the most preferred by the patients.

Browse IMARC Related Reports on Cardiovascular Devices Market:

• Brazil Cardiovascular Devices Market Report
   
• South Korea Cardiovascular Devices Market Report
   
• United States Cardiovascular Devices Market Report
   
• Saudi Arabia Cardiovascular Devices Market Report
   
• India Cardiovascular Devices Market Report